Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiosurgery | 4 | 2024 | 272 | 1.720 |
Why?
|
| Neoplasms | 5 | 2024 | 2898 | 1.110 |
Why?
|
| Lung Neoplasms | 4 | 2023 | 2262 | 0.910 |
Why?
|
| Liver Neoplasms | 3 | 2024 | 738 | 0.880 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2023 | 98 | 0.810 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2021 | 16 | 0.780 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2021 | 54 | 0.770 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 481 | 0.690 |
Why?
|
| MicroRNAs | 1 | 2023 | 534 | 0.650 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 1075 | 0.590 |
Why?
|
| Skin Neoplasms | 1 | 2021 | 546 | 0.550 |
Why?
|
| Colorectal Neoplasms | 1 | 2023 | 938 | 0.540 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2021 | 1077 | 0.470 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 1052 | 0.460 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 2903 | 0.330 |
Why?
|
| Humans | 16 | 2024 | 86678 | 0.260 |
Why?
|
| Motor Neuron Disease | 2 | 2014 | 21 | 0.250 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2023 | 17 | 0.240 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2024 | 69 | 0.230 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2023 | 70 | 0.230 |
Why?
|
| Tumor Microenvironment | 2 | 2023 | 418 | 0.220 |
Why?
|
| Radiation Pneumonitis | 1 | 2022 | 21 | 0.220 |
Why?
|
| Fluorouracil | 1 | 2023 | 556 | 0.200 |
Why?
|
| Neoplasm Metastasis | 2 | 2022 | 1056 | 0.200 |
Why?
|
| Pneumonia | 1 | 2022 | 179 | 0.190 |
Why?
|
| Neoplasm Staging | 2 | 2023 | 1939 | 0.190 |
Why?
|
| Retrospective Studies | 3 | 2023 | 8496 | 0.190 |
Why?
|
| Motivation | 1 | 2022 | 288 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 386 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2021 | 394 | 0.160 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 395 | 0.150 |
Why?
|
| Mass Screening | 1 | 2021 | 619 | 0.150 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2023 | 1313 | 0.140 |
Why?
|
| Cerebellum | 2 | 2014 | 247 | 0.140 |
Why?
|
| Neural Pathways | 2 | 2014 | 308 | 0.140 |
Why?
|
| Agenesis of Corpus Callosum | 1 | 2014 | 25 | 0.130 |
Why?
|
| Corpus Callosum | 1 | 2014 | 56 | 0.120 |
Why?
|
| Brain Mapping | 2 | 2014 | 549 | 0.120 |
Why?
|
| Mood Disorders | 1 | 2014 | 81 | 0.120 |
Why?
|
| Cerebral Cortex | 2 | 2014 | 584 | 0.120 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 2438 | 0.110 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2014 | 182 | 0.110 |
Why?
|
| Female | 5 | 2023 | 44550 | 0.110 |
Why?
|
| Nerve Net | 1 | 2014 | 366 | 0.100 |
Why?
|
| Middle Aged | 3 | 2023 | 25040 | 0.080 |
Why?
|
| Immunotherapy | 2 | 2022 | 629 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2014 | 3362 | 0.070 |
Why?
|
| Male | 4 | 2023 | 40988 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2022 | 4214 | 0.060 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2024 | 155 | 0.060 |
Why?
|
| Methylation | 1 | 2023 | 251 | 0.060 |
Why?
|
| Ipilimumab | 1 | 2022 | 58 | 0.050 |
Why?
|
| Immune System | 1 | 2022 | 93 | 0.050 |
Why?
|
| Time-to-Treatment | 1 | 2021 | 98 | 0.050 |
Why?
|
| RNA | 1 | 2023 | 560 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2022 | 1686 | 0.040 |
Why?
|
| Pyramidal Tracts | 1 | 2014 | 16 | 0.030 |
Why?
|
| Pons | 1 | 2014 | 24 | 0.030 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2014 | 31 | 0.030 |
Why?
|
| Anisotropy | 1 | 2014 | 62 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 67 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2504 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2601 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 1239 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2014 | 663 | 0.020 |
Why?
|
| United States | 1 | 2021 | 6681 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 3613 | 0.020 |
Why?
|
| Child | 1 | 2014 | 6928 | 0.010 |
Why?
|